Every story tagged Blood Oxygen Feature, curated for CIOs and IT leaders — ranked by source credibility, engagement, and freshness.
1 story · open in the command center
Apple has successfully defended its redesigned Apple Watch blood oxygen monitoring feature after the ITC closed Masimo's patent infringement case, allowing Apple to continue selling watches with the feature enabled in the US market. This resolution ends a multi-year legal battle that previously forced Apple to temporarily disable the feature and demonstrates the company's ability to engineer around patent disputes through technical redesign while maintaining product functionality. The case highlights the strategic importance of IP risk management and the potential for design-around solutions when facing patent challenges, though ongoing litigation risk remains as Masimo can still appeal.